Skip to main content

Phosphorylation

pharmacology

The attachment of a phosphate group to a protein by an enzyme, switching that protein's activity, location, or binding partners. It is one of the cell's principal control steps and it recurs throughout tolerance mechanisms: kinases phosphorylate a receptor that has been activated repeatedly, which recruits arrestin, pulls the receptor off the cell surface, and blunts the response to the next exposure.

Phosphorylation is the chemical attachment of a phosphate group (–PO₄) to a protein, carried out by a class of enzymes called kinases. The modification targets a specific amino acid residue — most often serine, threonine, or tyrosine — and changes the protein's three-dimensional shape, altering what it can do and which other molecules it will bind to.

The process is reversible. A second class of enzymes, called phosphatases, remove the phosphate group and return the protein to its prior state. This rapid, targeted, reversible switching makes phosphorylation one of the cell's most widely used signalling tools — it recurs in nearly every pathway that governs hormone responses, gene expression, and receptor sensitivity.

How it works · its role

Receptors on the cell surface are a principal target. When a receptor is activated repeatedly — by an agonist binding again and again — a group of kinases called G protein-coupled receptor kinases (GRKs) moves in and phosphorylates specific sites on the receptor's intracellular tail.

That phosphorylated tag recruits a protein called β-arrestin. Once arrestin binds, it physically blocks the receptor from coupling to its usual downstream signalling partners, halting transmission. Arrestin also connects the receptor to the cell's internalisation machinery: the receptor is pulled inside the cell and removed from the surface, a process called sequestration.

The net result is a receptor that cannot respond — even if the activating molecule is still present.

Relevance to substances & effects

Phosphorylation-driven desensitisation underlies tolerance to a wide range of psychoactive substance classes. Opioids repeatedly activating the mu-opioid receptor drive GRK phosphorylation of that receptor, reducing its surface availability and blunting the response to each successive dose. Cannabinoids trigger the same cascade at CB1 receptors; many stimulants and entactogens drive it at dopamine and serotonin receptors.

The speed and extent of phosphorylation varies by substance and receptor subtype — which partly explains why tolerance to different drugs develops at different rates. Substances that cause more receptor internalisation tend to produce faster functional tolerance, even at comparable levels of receptor occupancy.

Tolerance & dependence

Phosphorylation is the opening step in the tolerance cascade, but further adaptations compound it. With sustained exposure, the cell may reduce the total number of receptors it synthesises — a shift called downregulation — so that even after phosphorylated receptors are dephosphorylated and recycled, fewer surface receptors exist overall.

Recovery from this deeper adaptation takes longer than the hours required for simple dephosphorylation. It is one reason tolerance to some substance classes can outlast the acute phosphorylation cycle by days or weeks: the receptor complement is genuinely reduced, not merely switched off temporarily. Understanding this distinction matters for reading tolerance data — the rate of recovery reflects both the short-cycle reversal and this slower rebuilding process.

AI-generated · not yet verified by a human reviewer

Harm-reduction reference — not medical advice.

Last updated Aug 24, 2026Report an issue